UBS Group’s AllianzIM U.S. Equity 6 Month Buffer10 Mar/Sep ETF SIXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-125
Closed -$3.94K 11300
2025
Q4
$3.94K Buy
+125
New +$3.89K ﹤0.01% 8916
2025
Q3
Sell
-126
Closed -$3.69K 11053
2025
Q2
$3.69K Buy
+126
New +$3.51K ﹤0.01% 9329
2025
Q1
Sell
-144
Closed -$4.01K 10799
2024
Q4
$4.01K Buy
+144
New +$3.99K ﹤0.01% 8802
2024
Q3
Sell
-217
Closed -$5.7K 10164
2024
Q2
$5.7K Buy
217
+146
+206% +$3.74K ﹤0.01% 7969
2024
Q1
$1.81K Buy
+71
New +$1.79K ﹤0.01% 8047

Other funds holding SIXP

UBS Group's SIXP Position: Q1 2026 in Review

UBS Group sold out of AllianzIM U.S. Equity 6 Month Buffer10 Mar/Sep ETF (SIXP) in Q1 2026, closing a stake of 125 shares — an estimated $3.94K sold.

UBS Group first reported a position in SIXP in Q1 2024 and held it in 5 quarters. The position peaked at $5.7K in Q2 2024. 31 funds tracked by Wall St. Rank hold SIXP as of Q1 2026.

  • UBS Group reported no remaining AllianzIM U.S. Equity 6 Month Buffer10 Mar/Sep ETF position as of Q1 2026 after selling out during the quarter.
  • UBS Group sold 125 AllianzIM U.S. Equity 6 Month Buffer10 Mar/Sep ETF shares in Q1 2026, an estimated $3.94K.
  • UBS Group first reported a position in AllianzIM U.S. Equity 6 Month Buffer10 Mar/Sep ETF in Q1 2024 and held it in 5 quarters.
  • UBS Group's AllianzIM U.S. Equity 6 Month Buffer10 Mar/Sep ETF position peaked at $5.7K in Q2 2024.
  • 31 funds tracked by Wall St. Rank held AllianzIM U.S. Equity 6 Month Buffer10 Mar/Sep ETF as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.